Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DYRK2 is a dual-specificity kinase involved in regulating several key cellular processes, including cell cycle, apoptosis, and protein synthesis. It functions as a scaffold for E3 ubiquitin ligase complexes and phosphorylates substrates like 4E-BP1 and STIM1. DYRK2 is implicated in cancer biology and is being explored as a therapeutic target in oncology.
DYRK2 kinase inhibition leading to modulation of downstream signaling pathways (e.g., p53-dependent apoptosis, 4E-BP1 phosphorylation, STIM1 phosphorylation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2).